|
0800-0930
|
|
PL-03: Plenary 03
|
|
0800-0805
|
|
Welcome and Albert-Schweitzer Award Lecture Introduction
|
|
0805-0820
|
|
Albert-Schweitzer Award Lecture
|
|
0820-0835
|
|
European Association of Urology (EAU) Lecture: Equity, Diversity and Inclusion from the EAU Task Force Perspective
Maria Carmen Mir, Spain
|
|
0835-0850
|
|
American Urological Association (AUA) Lecture: Immunobiology of BCG Unresponsive Non-muscle Invasive Bladder Cancer
John Sfakianos, United States
|
|
0850-0905
|
|
State of the Art Lecture
|
|
0905-0925
|
|
Debate: Pelvic Lymphadenectomy (LND) in Bladder and Prostate Cancer
|
|
1025-1030
|
|
Closing Remarks
|
|
|
0800-1600
|
|
NURS: 8th SIU Global Nurses' Educational Symposium
Co-Chairs: Amparo Gudrun Camacho, United States / Meryem Yavuz Van Giersbergen, Türkiye
|
|
0930-1100
|
|
Global Andrology Forum Workshop: Management of Azoospermia – A Primer for the Urologist
|
|
0930-1100
|
|
Hot Topics: Are we Abreast with Future Urotech?
|
|
0930-1100
|
|
Instructional Course: Novel BPH Therapies - Review of Technologies and Practical Instruction (Itind, Urolift, Rezum, Aquablation, Stents, Aeep)
Chair: Dean Elterman, Canada
|
|
Recent advances in minimally invasive surgical procedures for BPH include UroLift, Rezum, iTind, and Aquablation. This 90 minute instructional course will focus on novel therapies and techniques for the treatment of BPH. The course will provide an overview of the technologies in terms of equipment, technical approach, and high-level review of clinical data. The faculty will provide first-hand practical instruction on best practices including patient selection, technique selection, and “tips and tricks”. The faculty will provide international experience and evidenced-based summaries of the risks and benefits of these procedures to aid with patient counselling for informed consent.
Learning Objectives:
At the end of this session, attendees should:
- Understand the mechanism of action and technique for each of the novel BPH therapies.
- Select the best patients for each procedure type based upon patient and prostate characteristics.
- Gain knowledge of the clinical data supporting the use of each modality and understand best-practice technique for each modality based upon the literature and expert opinion.
- Gain an appreciation for the challenges encountered and troubleshooting for each technology and appreciate the "tips & tricks" provided by the experts for performing these novel BPH therapies
|
|
|
|
0930-1100
|
|
Instructional Course: Transition from Transrectal to Transperineal Prostate Biopsy Under Local Anaesthesia in Your Clinic: A Crash Course
Chair: Peter Chiu, Hong Kong
|
|
Around the world, transrectal prostate biopsy is gradually being replaced by transperineal (TP) biopsy due to significantly less septic complications. However, traditional TP biopsy is usually done under general or spinal anaesthesia and is associated with higher anaesthetic risk and extra resources. TP biopsy under local anaesthesia (LA) has been proven to be well tolerated. This course focuses on the basics of TP biopsy under LA and the various means that we can perform systematic and MRI-guided TP biopsies. This serves to empower the participants to transform from TR to TP route of prostate biopsy under LA.
Learning Objectives:
At the end of this session, attendees should:
- Understand the benefits of transperineal prostate biopsy.
- Acquire the principles of local anaesthesia in transperineal prostate biopsy .
- nderstand the various ways and platforms to perform systematic and MRI-guided targeted transperineal prostate biopsy
|
|
0930-0935
|
|
Introduction
Peter Chiu, Hong Kong
|
|
0935-0950
|
|
Why biopsy the prostate transperineally?
Wayne Lam, Hong Kong
|
|
0950-1005
|
|
Techniques to Carry Out Peri-prostatic Anaesthetic Block to Perform Transperineal Prostate Biopsy
Peter Chiu, Hong Kong
|
|
1005-1020
|
|
Transperineal Prostate Biopsy Using Co-axial Needle and Device-assistance
Wayne Lam, Hong Kong
|
|
1020-1035
|
|
Transperineal Mri-ultrasound Fusion Targeted Prostate Biopsy: Cognitive vs Software-guided Platforms
Peter Chiu, Hong Kong
|
|
1035-1100
|
|
Interaction Discussion on Tips and Tricks in Achieving a Perfect MRI-guided Transperineal Prostate Biopsy
|
|
|
0930-1100
|
|
Interactive Session: Challenges in the Management of Non-Muscle Invasive Bladder Urothelial Cancer
Co-Chairs: Rakesh Heer, United Kingdom / Manish Patel, Australia
|
|
0930-1100
|
|
Interactive Session: Cytoreductive Nephrectomy – Contemporary Management
|
|
0930-1100
|
|
Joint SIU/Society of Urologic Robotic Surgeons (SURS) Session
|
|
0930-1100
|
|
Master Class: Issues and Approaches in the Management of Anterior Urethral Strictures
Co-Chairs: Pawan R Chalise, Nepal / Reynaldo Gómez, Chile
|
|
0930-1100
|
|
Master Video: Challenging Scenarios in Ureteroscopy – How to Approach
|
|
0930-1100
|
|
Resident's Mentoring Session
|
|
0930-1130
|
|
Workshop: Prostate MRI Reading and Fusion Biopsy
|
|
0930-1730
|
|
32nd Turkish Association of Urology (TAU) Meeting
|
|
0930-1730
|
|
Focal Therapy Society Conference
Co-Chairs: Jean de la Rosette, Türkiye / Jurgen Futterer, The Netherlands
|
|
Learning Objectives:
At the end of this session, attendees should:
- Understand about the different diagnostic imaging modalities for prostate carcinoma.
- Understand about the different biopsy protocols for prostate carcinoma.
- Understand about the different focal therapy options for localized prostate cancer.
- Understand about prevention and handling of complications from Focal Therapy.
- Understand the position of Focal Therapy within the armamentarium for treatment options of localized prostate carcinoma.
- Understand about the future directions of imaging modalities and focal therapy options for localized and advanced prostate carcinoma.
|
|
|
|
DIAGNOSTICS
Moderators
Baris Bakir, Türkiye
Sangeet Ghai, Canada
Badrinath Konety, United States
|
|
0930-0945
|
|
Transperineal Template Biopsies and Systematic Biopsies RIP
Massimo Valerio, Switzerland
|
|
0945-1000
|
|
MRI in Bore Biopsies are Best
Derya Yakar, The Netherlands
|
|
1000-1015
|
|
Fusion Biopsy – An Update
Samuel Chi-Hang Yee, Hong Kong
|
|
1015-1030
|
|
Micro Ultrasound – No Need for mpMRI
Laurence Klotz, Canada
|
|
1030-1045
|
|
Radiomics and AI in Radiology and Focal Therapy
To be announced
|
|
1045-1115
|
|
Round table on Diagnostics
Moderators
To be announced
Paolo Gontero, Italy
Panelists
Laurence Klotz, Canada
Massimo Valerio, Switzerland
Derya Yakar, The Netherlands
Samuel Chi-Hang Yee, Hong Kong
|
|
|
|
TREATMENT
Moderators
To be announced
Lukas Lusuardi, Austria
Lara Rodriguez Sanchez, Spain
|
|
1115-1130
|
|
Focal Cryotherapy
To be announced
|
|
1130-1145
|
|
Focal HIFU
To be announced
|
|
1145-1200
|
|
Focal IRE
José Luis Domínguez-Escrig, Spain
|
|
1200-1215
|
|
TULSA Current Status
Christian Pavlovich, United States
|
|
1215-1230
|
|
Histotripsy: update and the future
George R. Schade, United States
|
|
1230-1300
|
|
Round table on Treatment
Moderators
Antonio Finelli, Canada
Pilar Laguna, Türkiye
Panelists
José Luis Domínguez-Escrig, Spain
Christian Pavlovich, United States
George R. Schade, United States
|
|
1300-1400
|
|
Lunch Break
|
|
1400-1530
|
|
COMPLICATIONS
Moderators
To be announced
Alexander Govorov, Russia
Jack Tay, Singapore
|
|
1400-1415
|
|
Focal Therapy Follow up
Andre Luis de Castro Abreu, United States
|
|
1415-1430
|
|
Prevention and Handling of Complications
Giancarlo Marra, Italy
|
|
1430-1445
|
|
Salvage Radical Prostatectomy
Xavier Cathelineau, France
|
|
1445-1500
|
|
Salvage Ablation: Recent Updates and Techniques
To be announced
|
|
1500-1530
|
|
Round table on Complications
Moderator: To be announced
|
|
|
|
FUTURE DIRECTIONS
Moderators
To be announced
Kamran Bhatti, Qatar
Rahim Horuz, Türkiye
|
|
1530-1545
|
|
Focal Therapy Better than Active Surveillance?
Amir Lebastchi, United States
|
|
1545-1600
|
|
Focal Therapy Viable Treatment Option in GGG 3 or Higher ?
To be announced
|
|
1600-1615
|
|
Genomics in Focal Therapy
Rafael Sanchez-Salas, Canada
|
|
1615-1630
|
|
Novel PET Imaging Technologies
To be announced
|
|
1630-1645
|
|
Multiplex Imaging Oncology
To be announced
|
|
1645-1715
|
|
Round table on Future Directions
Moderator: To be announced
|
|
1715-1730
|
|
Take Home Message
Art Rastinehad, United States
|
|
|
1100-1130
|
|
Break
|
|
1130-1300
|
|
Balloon Debate
Co-Chairs: To be announced / Raed Azhar, Saudi Arabia
|
|
1130-1300
|
|
ePoster Session 09
|
|
1130-1300
|
|
ePoster Session 10
|
|
1130-1300
|
|
Instructional Course: Pelvic Organ Prolapse (POP): Challenges and Controversies
Chair: Liliya Tryfounyk, Ukraine
|
|
POP management options can potentially include observation,conservative,and surgical options.Surgical repair involve obliterative and reconstructive procedures. Each of these has its own risks and benefits. Many urologists,urogynecologists,and pelvicreconstructive surgeons are still unaware of,or less familiar with,the role,ease and reproducibility of such treatment options for POP and associated problems. There are specific areas of POP that the literature is sparse and supported by weak evidence,especially regarding their respective best management options. Attendees should be able to identify these and foster research on them. Evidence-based guidelines supported by multi-institutional RCTs must be encouraged and become available as soon as possible for all surgeons interested in pelvic reconstruction.
Learning Objectives:
At the end of this session attendees should:
- Understand the less known facts about pelvic organ prolapse (POP) and its associated problems (e.g., urinary incontinence, sexual dysfunction, etc.)
- To be familiar with the conservative management and the surgical techniques of POP repair
- To understand the challenges and controversies associated with this prevalent topic.
- To decide which treatment serves best an individual patient based on the compartments involved, extent of prolapse, medical and surgical comorbidities, risks of treatment, and shared decision-making involving the patient.
- To learn (and to review) the pertinent diagnostic workup of POP, including urodynamics, imaging studies, etc.
|
|
1130-1133
|
|
Introduction
Liliya Tryfounyk, Ukraine
|
|
1133-1143
|
|
Etiology, Epidemiology, Comorbidities and Evaluation
Ali Zumrutbas, Türkiye
|
|
1143-1153
|
|
Conservative and Surgical Management: Overview
Farzana Cassim, South Africa
|
|
1153-1203
|
|
Role of Synthetic Mesh in POP Reconstruction
Lysanne Campeau, Canada
|
|
1203-1213
|
|
Role of Hysterectomy in Middle Compartment POP
Liliya Tryfounyk, Ukraine
|
|
1213-1223
|
|
POP and Sexual Dysfunction
Francisco E. Martins, Portugal
|
|
1223-1233
|
|
POP and Stress Urinary Incontinence
Angelo Gousse, United States
|
|
1233-1243
|
|
Procidentia (Grade IV POP): Therapeutic Options
Lysanne Campeau, Canada
|
|
1243-1258
|
|
Q&A
|
|
1258-1300
|
|
Conclusion and Take-home messages
Ali Zumrutbas, Türkiye
|
|
|
1130-1300
|
|
Interactive Session: Oligometastatic Prostate Cancer – Current Management Strategies and Role of PET Imaging
|
|
1130-1300
|
|
Interactive Session: Urinary Diversion – Decision Making and Techniques
Co-Chairs: Mevlana Derya Balbay, Türkiye / Swapan Sood, India
|
|
1130-1300
|
|
Joint Society of Urologic Oncology (SUO) and the EAU Section of Oncological Urology (ESOU) Session
|
|
1130-1300
|
|
Master Class: Status of Open Radical Surgeries in the Current Era – Challenges
Co-Chairs: To be announced / Amlesh Seth, India
|
|
1300-1415
|
|
Luncheon Symposia
|
|
1300-1415
|
|
Networking Lunch
|
|
1415-1545
|
|
Hot Topics: Genito-urinary Trauma – Current Strategies and Challenges
|
|
1415-1545
|
|
ePoster Session 11
|
|
1415-1545
|
|
Instructional Course: How Can I Achieve 93% Success During ESWL
Chair: Kah Ann Git, Malaysia
|
|
ESWL was developed by using fluoroscopy, so most of our masters do not use ultrasound for localization and real time treatment tracking in adults and pediatric patients. Today, when ALARA principles are globally accepted for endourological procedures, we need to re-think the value of the ultrasound in our daily practice. Ultrasound Guided SWL have shown the same results as fluoroscopic procedures with benefits for patients and the working team. In summary, for renal and upper ureteral stones in adults an pediatric patients, ultrasound should be part of every day ESWL cases.
Learning Objectives:
At the end of this session, attendees should:
- Understand how technology influence ESWL outcome.
- Overcome the fear of using ultrasound guided ESWL and eventually capable of achieving good ESWL results
- Obtain knowledge of some fine techniques to improve SWL outcome.
- Experience some examples to gain tips and tricks to take home to practice ultrasound guided ESWL
|
|
|
|
1415-1545
|
|
Instructional Course: Radical Cystectomy and PLND for MIBC - Tips and Technique of Open, Robotic and Laparoscopic Approach
Chair: Sudhir Rawal, India
|
|
The aim is teach fine practical tips of doing radical cystectomy and standard, extended and super extended lymphadenectomy for MIBC. Also session will focus of Nerve sparing Radical cystectomy and Cystectomy in female.
Learning Objectives:
At the end of this session, attendees should:
- Learn tips and tricks of radical cystectomy in male.
- Learn tips and tricks of pelvic Lymphadenectomy.
- Learn tips and tricks of female radical cystectomy.
|
|
|
|
1415-1545
|
|
Interactive Session: Management of Advanced Prostate Cancer
|
|
1415-1545
|
|
Master Class: Active Surveillance and RPLND in Early Stage Germ Cell Tumors
Co-Chairs: Peter Albers, Germany / To be announced
|
|
1415-1545
|
|
Master Class: Sexual Dysfunction in Males
|
|
1415-1730
|
|
Resident's Forum
|
|
1545-1615
|
|
Break
|
|
1615-1745
|
|
ePoster Session 12
|
|
1615-1745
|
|
Instructional Course: Advanced Ureteroscopy: Solving Complex Problems
Chair: Michael Grasso, United States
|
|
This course is designed for the experienced endoscopist who wished to perform advanced ureteroscopic procedures including complex stone presentations, multimodality therapies for upper urinary tract urothelial carcinoma, and management strategies for the obstructed upper urinary tract. The internationally recognized faculty with emphasize pre-operative preparations, various imaging modalities, evolving instrumentation and accessories, and post operative care. Strategies to increase efficiency while minimizing complications will be emphasized. Management strategies addressing peri-operative complications will also be presented.
Learning Objectives:
At the end of this session, attendees should:
- Have a broad understanding of ureteroscopic technique and new innovative treatments
- Gain a comprehensive understanding of ureteroscopic lithotripsy techniques
- Be able to apply multimodality therapies for upper urinary tract urothelial carcinoma and upper urinary tract obstruction
- Reinforce preventative measures and treatment strategies for complications associated with RIRS
|
|
|
|
1615-1745
|
|
Instructional Course: Principles of Minimally Invasive Partial Nephrectomy
Chair: Gonzalo Vitagliano, Argentina
|
|
This session aims to provide safe and efficient practices in minimally invasive partial nephrectomy across SIU members. Our main target audience are urologists with limited experience performing these procedures. Disparities in practice patterns of minimally invasive partial nephrectomy (MIPN) exist across the globe. Furthermore, these procedures present a significant initial learning curve. Therefore, there is a need for practice standardization. In this course, SIU members will learn the necessary principles to perform a safe and efficient laparoscopic or robotic-assisted partial nephrectomies. During this session, the specific procedural details will be shared through a thoughtful step-by-step manner.
Learning Objectives:
At the end of this session, attendees should be able to:
- Perform their first MIPN an better their surgical practice by standardizing their minimally invasive partial nephrectomies.
- Understand principles of good and safe minimally invasive partial nephrectomy will allow participants to advance their surgical and oncologic practice.
|
|
|
|
1615-1745
|
|
Master Class: Managing PUV – Options and Challenges
|
|
1615-1745
|
|
Master Class: Prostate Cancer Diagnosis –MRI, Biomarkers, Who to Biopsy and Active Surveillance
Co-Chair: Marc Dall'Era, United States
|
|
1615-1745
|
|
Master Video: Renal Preservation in Upper Tract Malignancy
Co-Chairs: To be announced / Michael Poch, United States
|
|
1615-1745
|
|
Semi-Live Surgery Interactive Session
|
Session will be available live and/or on-demand on [email protected]
